Cargando…
SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes
IMPORTANCE: In the absence of evidence of clinical utility, the United States' Centers for Disease Control and Prevention does not currently recommend the assessment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike-protein antibody levels. Clinicians and their patients, esp...
Autores principales: | Kaufman, Harvey W., Letovsky, Stanley, Meyer, William A., Gillim, Laura, Assimon, Magdalene M., Kabelac, Carly A., Kroner, John W., Reynolds, Shannon L., Eisenberg, Marcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407563/ https://www.ncbi.nlm.nih.gov/pubmed/37559735 http://dx.doi.org/10.3389/fpubh.2023.1193246 |
Ejemplares similares
-
Antibody titer levels and the effect on subsequent SARS-CoV-2 infection in a large US-based cohort
por: Sullivan, Adam, et al.
Publicado: (2023) -
Follow-Up SARS-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US
por: Sullivan, Adam, et al.
Publicado: (2021) -
Auxiliary Screening COVID-19 by Serology
por: Pan, Xiongfeng, et al.
Publicado: (2022) -
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
por: Reynolds, Shannon L., et al.
Publicado: (2023) -
Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)